Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | BASF Plant Science GmbH | 358 |
| 2 | Kyowa Kirin Co Ltd | 146 |
| 3 | Dana Farber Cancer Institute Inc | 142 |
| 4 | F Hoffmann La Roche AG | 115 |
| 5 | BASF SE | 109 |
| 6 | Chugai Pharmaceutical Co Ltd | 97 |
| 7 | Qiagen GmbH | 96 |
| 8 | Takeda Pharmaceutical Co Ltd | 93 |
| 9 | Exact Sciences Corp | 92 |
| 10 | Janssen Biotech Inc | 82 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | C12N | Microorganisms, enzymes | 4,983 |
| 2 | C07K | Peptides | 3,953 |
| 3 | C12Q | Measuring/testing involving enzymes | 3,855 |
| 4 | A61K | Medicinal preparations | 3,100 |
| 5 | G01N | Investigating / analysing materials | 2,302 |
| 6 | A61P | Therapeutic activity (drug indications) | 2,286 |
| 7 | B01L | 695 | |
| 8 | Y02A | Climate change adaptation | 570 |
| 9 | C12Y | Enzyme nomenclature (EC numbers) | 528 |
| 10 | C12P | Fermentation, enzyme processes | 500 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionMost-cited patents
Patents ranked by forward citations reveal the foundational inventions the field continues to build on.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Extraction of DNA by boiling cells in an alkaline phenol/guanidine thiocyanate solution | 1999 | Mayo Clinic in Florida | 41 |
| Hybridization buffer containing guanidine thiocyanate | 2018 | Abbott Molecular Inc | 6 |
| HYBRIDIZATION BUFFERS COMPRISING GUANIDINIUM THIOCYANATE | 2017 | Abbott Molecular Inc | 2 |
| Preparation method of guanidine thiocyanate | 2021 | SUZHOU YACOO SCIENCE Co.,Ltd. | 1 |
| Production method of guanidinium thiocyanate | 2013 | WU JIAWANG | 1 |
Where research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Amino Acid Enzymes and Metabolism | 1 |
| 2 | Bone and Dental Protein Studies | 1 |
| 3 | Glaucoma and retinal disorders | 1 |
| 4 | MicroRNA in disease regulation | 1 |
| 5 | Molecular Biology Techniques and Applications | 1 |
| 6 | Neuroscience and Neuropharmacology Research | 1 |
| 7 | Pulmonary Hypertension Research and Treatments | 1 |
| 8 | Renal and related cancers | 1 |
| 9 | Wildlife Ecology and Conservation | 1 |
Technology trend analysis
Cypris uses AI to connect emerging research themes to IP activity, commercialization signals, and underexplored opportunity areas.
See Cypris in actionWho's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Alasdair J. Edgar | King's College London | 6 |
| 2 | Brigitte Berger‐Bächi | University of Zurich | 5 |
| 3 | Claudia Miccolo | Fondazione IRCCS Istituto Neurologico Carlo Besta | 2 |
| 4 | Jui‐Yoa Chang | The University of Texas at Austin | 3 |
| 5 | Alfredo Fusco | University of Naples Federico II | 2 |
| 6 | Amane Makino | Tohoku University | 2 |
| 7 | André Rosenthal | Signature Research (United States) | 2 |
| 8 | Ashfaque A. Memon | Aarhus University Hospital | 2 |
| 9 | Benno Mann | Augusta-Kranken-Anstalt | 2 |
| 10 | Bernd Hinzmann | Signature Research (United States) | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| The single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction: twenty-something years on | 2006 | 2075 | Molecular Biology Techniques and Applications |
| Rickettsial Infection in Animals and Brazilian Spotted Fever Endemicity | 2005 | 424 | Vector-borne infectious diseases |
| Phylogeography and Genetic Ancestry of Tigers (Panthera tigris) | 2004 | 288 | Genetic diversity and population structure |
| Collecting, archiving and processing DNA from wildlife samples using FTA® databasing paper | 2004 | 272 | Forensic and Genetic Research |
| Bat Nipah Virus, Thailand | 2005 | 258 | Virology and Viral Diseases |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition of guanidine thiocyanate?
Which organizations hold the most patents involving guanidine thiocyanate?
What are the main patent classification areas for guanidine thiocyanate applications?
What is a notable application of guanidine thiocyanate documented in patent literature?
What highly-cited research paper demonstrates the use of guanidine thiocyanate in molecular biology?